🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/02/1990 | 11,29 | 11,59 | 11,23 | 11,57 | +3,01% | 3,17% | 4.248.173 |
| 06/02/1990 | 11,45 | 11,47 | 11,23 | 11,23 | -1,91% | 2,08% | 4.313.568 |
| 05/02/1990 | 11,55 | 11,57 | 11,43 | 11,45 | -0,69% | 1,21% | 3.533.856 |
| 02/02/1990 | 11,43 | 11,67 | 11,41 | 11,53 | +0,69% | 2,26% | 2.816.395 |
| 01/02/1990 | 11,57 | 11,57 | 11,45 | 11,45 | -0,35% | 1,03% | 3.881.582 |
| 31/01/1990 | 11,47 | 11,49 | 11,37 | 11,49 | +0,87% | 1,04% | 5.782.445 |
| 30/01/1990 | 11,47 | 11,51 | 11,21 | 11,39 | -0,69% | 2,60% | 4.825.411 |
| 29/01/1990 | 11,45 | 11,59 | 11,29 | 11,47 | +0,17% | 2,60% | 2.930.208 |
| 26/01/1990 | 11,35 | 11,51 | 11,13 | 11,45 | +1,05% | 3,33% | 4.505.981 |
| 25/01/1990 | 11,63 | 11,69 | 11,29 | 11,33 | -1,89% | 3,42% | 4.668.840 |
| 24/01/1990 | 11,13 | 11,67 | 11,09 | 11,55 | +1,04% | 5,18% | 9.399.931 |
| 23/01/1990 | 11,33 | 11,55 | 11,27 | 11,43 | +1,41% | 2,46% | 8.052.413 |
| 22/01/1990 | 11,69 | 11,71 | 11,21 | 11,27 | -3,57% | 4,25% | 5.038.574 |
| 19/01/1990 | 11,77 | 11,77 | 11,69 | 11,69 | +0,68% | 0,68% | 5.465.530 |
| 18/01/1990 | 11,45 | 11,61 | 11,39 | 11,61 | +1,39% | 1,91% | 6.850.147 |
| 17/01/1990 | 11,65 | 11,73 | 11,45 | 11,45 | -1,54% | 2,39% | 8.384.419 |
| 16/01/1990 | 11,45 | 11,65 | 11,27 | 11,63 | -0,17% | 3,30% | 11.656.066 |
| 15/01/1990 | 11,89 | 11,95 | 11,65 | 11,65 | -2,50% | 2,51% | 8.830.238 |
| 12/01/1990 | 12,01 | 12,11 | 11,91 | 11,95 | -2,43% | 1,66% | 7.641.806 |
| 11/01/1990 | 12,25 | 12,34 | 12,21 | 12,25 | +0,82% | 1,14% | 3.660.874 |
| 10/01/1990 | 12,25 | 12,38 | 12,09 | 12,15 | -1,29% | 2,44% | 6.274.795 |
| 09/01/1990 | 12,40 | 12,48 | 12,31 | 12,31 | -0,80% | 1,44% | 3.694.200 |
| 08/01/1990 | 12,25 | 12,46 | 12,23 | 12,40 | +1,30% | 1,95% | 4.405.373 |
| 05/01/1990 | 12,46 | 12,66 | 12,25 | 12,25 | -2,07% | 3,35% | 6.739.478 |
| 04/01/1990 | 12,70 | 12,72 | 12,38 | 12,50 | -1,57% | 2,66% | 4.758.758 |
| 03/01/1990 | 12,56 | 12,72 | 12,56 | 12,70 | +1,59% | 1,27% | 7.958.722 |
| 02/01/1990 | 12,29 | 12,50 | 12,19 | 12,50 | +1,45% | 2,59% | 7.453.795 |
| 29/12/1989 | 12,25 | 12,33 | 12,21 | 12,33 | +0,65% | 0,97% | 3.033.960 |
| 28/12/1989 | 12,13 | 12,25 | 12,11 | 12,25 | +0,65% | 1,15% | 3.014.467 |
| 27/12/1989 | 12,03 | 12,17 | 11,99 | 12,17 | +0,99% | 1,49% | 5.159.933 |